Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,491.36
    -1,731.75 (-3.45%)
     
  • CMC Crypto 200

    1,261.13
    -96.88 (-7.13%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Company News for Dec 1, 2021

  • Chico's FAS, Inc.’s CHS shares rose 3.2% after the company reported third-quarter 2021 earnings of 18 cents per share, beating the Zacks Consensus Estimate of a loss of 3 cents.

  • Shares of Citi Trends, Inc. CTRN jumped 8.4%after the company reported third-quarter 2021 earnings of $1.03 per share, beating the Zacks Consensus Estimate of 48 cents.

  • ImmunoGen, Inc.’s IMGN shares surged 29.9% after the company announced positive topline data from the SORAYA trial of mirvetuximab soravtansine for ovarian cancer.

  • Shares of ERYTECH Pharma S.A. ERYP jumped 13.6% after the company secured US patent directed to sequential use of methioninase & asparaginase against solid tumors.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Chico's FAS, Inc. (CHS) : Free Stock Analysis Report
 
Citi Trends, Inc. (CTRN) : Free Stock Analysis Report
 
ImmunoGen, Inc. (IMGN) : Free Stock Analysis Report
 
Erytech Pharma SA Sponsored ADR (ERYP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research